Evaluation of OHIP-14 and OSHIP-14 in Patients With Varying Periodontal Disease
Cross-Section
1 other identifier
observational
300
1 country
1
Brief Summary
This study aims to evaluate periodontal health status and its impact on oral health-related quality of life by combining clinical periodontal parameters with validated patient-reported outcome measures. Periodontal assessments included probing pocket depth (PPD), clinical attachment loss (CAL), gingival index (GI), plaque index (PI), and bleeding on probing (BOP). Participants were further classified according to periodontal disease staging and grading. To assess the subjective impact of periodontal conditions on daily life, the Oral Health Impact Profile-14 (OHIP-14) and its shortened version, the Oral Health Impact Profile-14 short form (OShip-14), were administered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 5, 2026
CompletedApril 22, 2026
April 1, 2026
6 months
April 16, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
OSHİP-14
OShip-14 is a 14-item short-form questionnaire designed to assess oral health-related quality of life, evaluating the physical, psychological, and social impacts of oral and dental health on daily life.
One-time assessment at enrollment
Study Arms (4)
Stage I Periodontitis (Mild)
Participants with mild periodontitis characterized by initial periodontal breakdown, probing pocket depth (PPD) ≤4 mm, and minimal clinical attachment loss (CAL).
Stage II Periodontitis (Moderate)
Participants with moderate periodontitis characterized by PPD ≤5 mm and moderate CAL without significant functional impairment or tooth loss.
Group 3: Stage III Periodontitis (Severe)
Participants with severe periodontitis characterized by PPD ≥6 mm, advanced CAL, furcation involvement, and increased risk of tooth loss
Group 4: Stage IV Periodontitis (Advanced)
Participants with advanced periodontitis characterized by extensive attachment loss, severe bone destruction, and impaired masticatory function or tooth loss.
Interventions
Participants underwent a comprehensive periodontal examination, including probing pocket depth (PPD), clinical attachment loss (CAL), gingival index (GI), plaque index (PI), and bleeding on probing (BOP) assessments. In addition, oral health-related quality of life was evaluated using the OHIP-14 and OShip-14 questionnaires. No therapeutic or pharmacological intervention was applied.
Eligibility Criteria
Systemically healthy individuals aged 18-65 years diagnosed with periodontitis and willing to participate in the study.
You may qualify if:
- Aged between 18 and 65 years Diagnosed with periodontitis (any stage) Willing to participate in the study and provide informed consent
You may not qualify if:
- Refusal to participate in the study Pregnancy or lactation Use of antibiotics or anti-inflammatory drugs within the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bolu Abant Izzet Baysal University
Bolu, 14100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 9 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 16, 2026
First Posted
April 22, 2026
Study Start
September 1, 2025
Primary Completion
March 1, 2026
Study Completion
May 5, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to protect patient privacy and confidentiality.